Role of high-dose interleukin-2 for melanoma in the age of cellular therapy. - Buchbinder E; Lotze MT; Margolin KA; Amaria R; Sarnaik A; Seery V; Eroglu Z; Khaddour K; Betof Warner A; Kluger HM; Sznol M; Atkins MB; et al. (Journal for immunotherapy of cancer, 2025)